T cell protection
T cells from common colds cross-protect against infection with SARS-CoV-2
People with higher levels of T cells from common cold coronaviruses are less likely to become infected with SARS-CoV-2.
T cells from common colds cross-protect against infection with SARS-CoV-2
People with higher levels of T cells from common cold coronaviruses are less likely to become infected with SARS-CoV-2.
COVID-19 experts from Imperial and Singapore share lessons from pandemic
Scientists from the UK and Singapore have come together to discuss their research during the COVID-19 pandemic at an online symposium.
Immune imprinting causes varied patterns of protection against COVID-19 variants
Research shows that the first SARS-CoV-2 spike protein a person encounters, be it by vaccination or infection, shapes their subsequent immune response
$2 million investment for study investigating how vaccines work inside cells
A new $2 million project will help study how our ancestry and diversity influence the way vaccines work in our cells.
Research reveals how ‘chaperone’ proteins deal with immune system overreactions
Scientists have discovered how special proteins in the blood prevent our immune system from harming our own cells with overproduced molecules.
Professor Petter Brodin joins Imperial as Garfield Weston Chair of Neonatology
Petter Brodin has been appointed as the Garfield Weston Chair of Neonatology and Professor of Paediatric Immunology at Imperial College London.
Feature
A life in paediatric HIV research and care: Prof Gareth Tudor-Williams retires
Professor Gareth Tudor-Williams has retired after a career spanning over three decades in paediatric HIV research and care.
New vaccine study to investigate durability of COVID-19 immunity
UK Research and Innovation (UKRI) funding will support new research into the durability of COVID-19 immunity after vaccination and natural infection.
Histamine could be a key player in depression, according to study in mice
Bodily inflammation dampens levels of a ‘feel-good molecule’ and antidepressants’ ability to boost them, according to new research in mice.
4
Third mRNA COVID vaccine dose could benefit immunocompromised dialysis patients
People who attend hospital for their dialysis treatment (haemodialysis) could benefit from an early third dose of an mRNA COVID-19 vaccine.